American Century Companies Inc. Lowers Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

American Century Companies Inc. lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,798,270 shares of the company’s stock after selling 551,075 shares during the quarter. American Century Companies Inc.’s holdings in Henry Schein were worth $332,040,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. FMR LLC lifted its position in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP raised its position in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Henry Schein by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock worth $82,464,000 after purchasing an additional 16,616 shares during the last quarter. ING Groep NV raised its position in shares of Henry Schein by 34.1% in the 4th quarter. ING Groep NV now owns 1,163,087 shares of the company’s stock worth $80,486,000 after purchasing an additional 295,785 shares during the last quarter. Finally, Stifel Financial Corp raised its position in shares of Henry Schein by 1.2% in the 3rd quarter. Stifel Financial Corp now owns 1,122,455 shares of the company’s stock worth $81,827,000 after purchasing an additional 13,180 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Trading Down 1.5 %

Henry Schein stock opened at $69.39 on Friday. The business has a 50-day simple moving average of $74.82 and a two-hundred day simple moving average of $72.60. The company has a market cap of $8.62 billion, a P/E ratio of 28.56, a P/E/G ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.66 earnings per share. Analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

HSIC has been the subject of several recent analyst reports. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, UBS Group reduced their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.